CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.15 -4.89 (-9.77%)
At close: Nov 10, 2026 · 4:00 PM EST

CRISPR Therapeutics AG (CRSP) Operating Margin (2016 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) recorded Operating Margin of -1026.48% in Q3 2026, up 13828.30 percentage points from -14854.78% a year earlier and up 125.36 percentage points from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Operating Margin (2016 - 2026) Analysis & Trends

On a TTM basis, CRISPR Therapeutics AG's Operating Margin came in at -2114.75% as of Sep 30, 2026, down 616.48 percentage points year-over-year; for FY2025, it was -18933.65%, down 17683.27 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of +30361.90 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -1250.38% in FY2024 (-1190.43 pp), -59.95% in FY2023 (+56130.45 pp), -56190.40% in FY2022 (-56231.23 pp) and 40.82% in FY2021 (+49336.37 pp).
  • The Q3 2026 figure is the highest quarterly Operating Margin since Q4 2024.
  • On a year-over-year basis, Operating Margin has increased for three consecutive quarters, with an average year-over-year change of +5798.35 percentage points over the last eight quarters.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 2192384.58 percentage points in Q4 2023, against a drop of 2191220.47 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1151.84% (Q2 2026), -8933.33% (Q1 2026) and -17912.50% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 24.35%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 36.01%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 32.97%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 20.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.79%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 41.71%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 32.98%
10 CRISPR Therapeutics AG 4.65 Bn -4.41 Bn - -1,026.48%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1,026.48%
Jun 30, 2026 -1,151.84%
Mar 31, 2026 -8,933.33%
Dec 31, 2025 -17,912.50%
Sep 30, 2025 -14,854.78%
Jun 30, 2025 -25,708.97%
Mar 31, 2025 -17,158.84%
Dec 31, 2024 -180.96%
Sep 30, 2024 -18,294.02%
Jun 30, 2024 -29,257.25%
Mar 31, 2024 -27,894.25%
Dec 31, 2023 34.58%
Jun 30, 2023 -136.03%
Mar 31, 2023 -64.49%
Dec 31, 2022 -2,192,350.00%
Sep 30, 2022 -194,029.79%
Jun 30, 2022 -115,987.34%
Mar 31, 2022 -18,720.43%
Dec 31, 2021 -1,129.53%
Sep 30, 2021 -15,637.01%
API Access

CRISPR Therapeutics AG Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY